Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

Study Identifier
P14-506
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Parkinson's Disease
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years

    Protocol Summary

    This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with Duodopa (levodopa/carbidopa intestinal gel).

    Study Locations

    Location
    Status
    Location
    University of Calgary /ID# 151948
    Calgary, Alberta, Canada, T2N 4Z6
    Status
    Not applicable
    Location
    Zeidler Ledcor Centre /ID# 135979
    Edmonton, Alberta, Canada, T6G 2X8
    Status
    Not applicable
    Location
    St. Boniface Clinic, CA /ID# 162092
    Winnipeg, Manitoba, Canada, R2H 2A5
    Status
    Not applicable
    Location
    Hamilton Health Sciences /ID# 148808
    Hamilton, Ontario, Canada, L8L 2X2
    Status
    Not applicable
    Location
    Kingston General Hospital /ID# 144942
    Kingston, Ontario, Canada, K7L 2V7
    Status
    Not applicable
    Location
    London Health Sciences Centre /ID# 138434
    London, Ontario, Canada, N6A 5A5
    Status
    Not applicable
    Showing {first} - {last} of {total} Results